NCT07078500
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
NCT06219356
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
NCT07126678
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT07124936
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China
NCT03765177
- Conditions
- Acute Lymphoblastic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
- Locations
-
- Vancouver General Hospital Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- The Ottawa Hospital - General Campus Ottawa, Ontario, Canada
NCT05583071
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Klinikum Stuttgart - Katharienenhospital Stuttgart, Baden-Wurttemberg, Germany
- Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Würtemberg, Germany
- University of Cologne Cologne, Germany
- Universitätsklinikum Hamburg-Eppendorf Hamburg, Hamurg, Germany
Recruiting
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT06792825
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
NCT05667506
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
- Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
- Nanfang Hospital Guangzhou, Guangdong, China
Recruiting
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
NCT06375733
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Guangxi Medical University Cancer Hospital&Guangxi Cancer Institute Nanning, China
- Affiliated Cancer Hospital of Zhengzhou University Henan Cancer Hospital Zhengzhou, China
NCT06530550
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China